REQUEST A DEMO
Total
USD $0.00
Search more companies

Grupo Renal Valledupar S.A.S (Colombia)

Main Activities: Ambulatory Health Care Services
Secondary Activities: Other Ambulatory Health Care Services | Nursing Care Facilities (Skilled Nursing Facilities)
Full name: Grupo Renal Valledupar S.A.S Profile Updated: March 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Spanish Download a sample report

Grupo Renal Valledupar S.A.S is an enterprise in Colombia, with the main office in Valledupar. The enterprise operates in the Ambulatory Health Care Services industry. Grupo Renal Valledupar S.A.S was incorporated on November 15, 2016. From the latest financial highlights, Grupo Renal Valledupar S.A.S reported a net sales revenue drop of 64.38% in 2022. Its’ total assets recorded a negative growth of 6.49%.

Headquarters
Cl 16B 9 74 Lc 101
Valledupar; Cesar;

Contact Details: Purchase the Grupo Renal Valledupar S.A.S report to view the information.

Basic Information
Outstanding Shares:
Purchase the Grupo Renal Valledupar S.A.S report to view the information.
Incorporation Date:
November 15, 2016
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Grupo Renal Valledupar S.A.S report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
-64.38%
Total operating revenue
-64.38%
Operating profit (EBIT)
N/A
EBITDA
N/A
Net Profit (Loss) for the Period
N/A
Total assets
-6.49%
Total equity
-20.55%
Operating Profit Margin (ROS)
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Quick Ratio
-0.34%
Cash Ratio
0.02%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?